Abstract The study of the development of anti-cancer drugs and preclinical toxicity tests has until today encountered a major problem identified as lack of a reliable in vitro-tumor model able to mimic in vivo conditions. These models provide a clear basis for understanding tumor-development processes and assists in the selection of agents from various chemicals…